Science Blockchain Releases Q3 2022 SCI Token NAV
Santa Monica, CA — November 3, 2022 — Science Blockchain Pte Ltd.,the premier startup studio investing in and building blockchain technology companies, today announces that the NAV of each SCI token as of September 30, 2022 is $1.40, based on the NAV of the underlying portfolio Science Blockchain Holdings, LP. Note: the NAV does not include portfolio company tokens that have been previously distributed to tokenholders.*
The NAV is a $0.03 decrease from the $1.43 NAV reported for the period ending June 30, 2022. The decrease in NAV is primarily due to the decrease in spot pricing of BTC since 6/30 and the Fund’s treasury management strategies, minus fees and expenses.
This quarter, Protego named Ron Totaro, whose most recent role was CEO at Tassat Group, as CEO — read more in CoinDesk and American Banker. Insider highlighted Protego in its list of disruptive fintechs.
Science Blockchain investment Dapper Labs unveiled a partnership with Ticketmaster to issue NFTs for live events. The NFTs act as shareable forms of digital memorabilia, and more than 5 million have been minted on the Flow blockchain. Read more in the release here.
RealBlocks appointed Simon McKay as Managing Director of Distribution and a Portfolio Manager for RealBlocks Investment Advisor. He brings more than 20 years experience working with leading asset management firms across different functions, including investment advisory, business development, corporate strategy, and product management.
The next token upgrade event is scheduled for Q4 2022. Beginning this fiscal year, token upgrades will be completed on a biannual basis. Please ensure you have completed the upgrade process — including registering a wallet that you control — in order to receive SCI2 tokens. For those who are holding tokens in treasury and have registered a wallet address, we will also conduct SCI2 disbursements from treasury to registered wallets during the upgrade. Token distribution events to new SCI2 tokenholders will follow the upgrade and treasury disbursements — these events will include any undistributed portfolio tokens. Please note: Portfolio company tokens, including those held on Tokenhub as well as future portfolio company token distributions, will ONLY be distributed to those token holders who have completed the token upgrade process and hold SCI2 tokens in a registered wallet.
The Science Blockchain portfolio includes the following:
- Cash
- Bitcoin (BTC)
- Ethereum (ETH)
- Protego Trust Company (equity)
- RealBlocks [Envexergy] (equity)
- Wave Financial Group (equity)
- Dapper Labs (equity) via RCapital SPV VI
- Other token investments
You can find the breakdown of the Science Blockchain portfolio below:
*Total portfolio company tokens previously distributed to token holders as of September 30, 2022:
The Science Blockchain team appreciates the trust and support of the SCI token holders and is committed to earning that trust each day through executing on its investment strategy.
As a reminder, all original SCI tokens, including those remaining on Tokenhub, are now frozen. Upgraded SCI tokens are available through the Securitize platform and the upgrade process is now open to all Science Blockchain investors at https://science.securitize.io. All SCI token holders who received their tokens via Tokenhub as part of the original issuance of the SCI tokens have received an email at the email address provided during the original SCI issuance process with instructions on how to access their Science Blockchain Investor Dashboard. Token holders can also access their dashboard directly by registering using that same email via https://science.securitize.io/.
The latest token upgrade process was completed in June 2022. The Science Blockchain Investor Dashboard is now live at science.securitize.io. The Science Blockchain Investor Dashboard also allows token holders to manage their SCI2 tokens once they have completed the upgrade process and have received SCI2 tokens.
Reminder for token holders to complete the token upgrade process if they have not already done so. In order to receive SCI2 tokens in future upgrades, you MUST register a wallet address. Further, token holders will need to have upgraded SCI tokens (SCI2 tokens) in a registered wallet in order to receive portfolio company tokens that were held on Tokenhub and portfolio company token distributions. Please visit https://science.securitize.io for more information and to complete the upgrade process as soon as possible.
SCI Token holders are encouraged to register and visit https://www.science-inc.com/blockchain.html for current information.
About Science Blockchain
Science has been helping entrepreneurs build successful businesses for more than six years, during which time it has funded or founded more than 85 companies, and has had $1.3B in aggregate portfolio company exits. Science Blockchain, the first incubator in the world to be funded by its own tokenized compliant securities offering (token: SCI), intends to continue this history of successful company building by helping incredible blockchain entrepreneurs create and scale the software giants of the next century. We do this in three primary ways: 1) incubating promising early stage blockchain ventures, 2) engaging on a very limited and selective basis, with companies looking to take advantage of the possibilities presented by tokenized economies, and 3) investing in compliant private offerings of blockchain businesses. The unique token structure of SCI allows us to distribute 70% of the total tokens that Science Blockchain receives through our incubation and investment strategies directly to the SCI token holders. For more details, please visit https://www.science-inc.com/blockchain.html.
Disclaimer: This document contains certain forward-looking statements, relating to Science Inc.’s business, which can be identified by the use of forward-looking terminology such as “promising”, “plans”, “anticipated”, “will”, “project”, “believe”, “forecast”, “expected”, “estimated”, “targeting”, “aiming”, “set to”, “potential”, “seeking to”, “goal”, “could provide”, “intends”, “is being developed”, “could be”, “on track”, or similar expressions, or by express or implied discussions regarding potential filings or marketing approvals, or potential future sales of product candidates. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated or expected. Science Inc. is providing this information as of the date of this document and does not assume any obligation to update any forward-looking statements contained in this document as a result of new information, future events or developments or otherwise.
